Nova (NMR) Stock Forecast & Price Target
NMR Analyst Ratings
NMR Stock 12 Month Forecast
Average Price Target
EUR 461.63▲(57.02% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Atif Malik | Citi | EUR 490.82→EUR 370.35 | hold | 25.97%Upside | Downgraded | 10/09/26 | ||
| Thomas O'Malley | Barclays | EUR 535.44 | buy | 82.12%Upside | Reiterated | 08/07/26 | ||
| Charles Shi | Needham | EUR 508.67 | buy | 73.02%Upside | Reiterated | 08/07/26 | ||
| Shane Brett CFA | Morgan Stanley | EUR 481.90→EUR 411.40 | hold | 39.93%Upside | Assigned | 08/07/26 | ||
| Vedvati Shrotre | Evercore ISI | EUR 535.44→EUR 423.89 | buy | 44.18%Upside | Reiterated | 08/07/26 | ||
| Michael Mani | Bank of America Securities | ― | buy | ― | Reiterated | 08/07/26 | ||
| Blayne Curtis | Jefferies | EUR 571.14→EUR 535.44 | buy | 82.12%Upside | Assigned | 08/06/26 | ||
| Matthew Prisco | Cantor Fitzgerald | EUR 535.44→EUR 446.20 | buy | 51.77%Upside | Reiterated | 08/06/26 | ||
| Shay Zigelman | Bank Hapoalim | EUR 389.36 | hold | 32.44%Upside | Downgraded | 02/16/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Atif Malik | 10/09/26 | EUR 490.82→EUR 370.35 | hold | 25.97%Upside | Downgraded | Citi | ||
| Thomas O'Malley | 08/07/26 | EUR 535.44 | buy | 82.12%Upside | Reiterated | Barclays | ||
| Charles Shi | 08/07/26 | EUR 508.67 | buy | 73.02%Upside | Reiterated | Needham | ||
| Shane Brett CFA | 08/07/26 | EUR 481.90→EUR 411.40 | hold | 39.93%Upside | Assigned | Morgan Stanley | ||
| Vedvati Shrotre | 08/07/26 | EUR 535.44→EUR 423.89 | buy | 44.18%Upside | Reiterated | Evercore ISI | ||
| Michael Mani | 08/07/26 | ― | buy | ― | Reiterated | Bank of America Securities | ||
| Blayne Curtis | 08/06/26 | EUR 571.14→EUR 535.44 | buy | 82.12%Upside | Assigned | Jefferies | ||
| Matthew Prisco | 08/06/26 | EUR 535.44→EUR 446.20 | buy | 51.77%Upside | Reiterated | Cantor Fitzgerald | ||
| Shay Zigelman | 02/16/26 | EUR 389.36 | hold | 32.44%Upside | Downgraded | Bank Hapoalim |
Best Analysts Covering Nova
Copying Vedvati Shrotre's trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +6.25% per trade.
Copying Vedvati Shrotre's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +27.33% per trade.
Copying Vedvati Shrotre's trades and holding each position for 2 Years would result in 69.23% of your transactions generating a profit, with an average return of +36.85% per trade.
NMR Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 3 | 3 | 3 | 0 |
| Buy | 8 | 6 | 5 | 5 | 0 |
| Hold | 1 | 1 | 1 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 9 | 10 | 9 | 10 | 1 |
In the current month, NMR has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NMR average Analyst price target in the past 3 months is 461.63.
NMR Financial Forecast
NMR Earnings Forecast
Next quarter’s earnings estimate for NMR is EUR 2.48 with a range of EUR 2.43 to EUR 2.51. The previous quarter’s EPS was EUR 2.25. Its overall industry beat the EPS estimate 49.22% of the time in the past 12 months.
NMR Sales Forecast
Next quarter’s sales forecast for NMR is EUR 252.63M with a range of EUR 252.50M to EUR 252.95M. The previous quarter’s sales results were EUR 228.29M. Its overall industry beat sales estimates 53.85% of the time in the past 12 months.
